Ivarmacitinib Sulfate Tablets
Ivarmacitinib Sulfate Tablets entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.
Timeline
Mon, 10 Aug 2026 03:17:35 GMTHengrui Pharma Gets Nod to Add Fifth Indication for Ivarmacitinib Sulfate Tablets - Moomoo
Thu, 06 Aug 2026 13:57:29 GMTHengrui Pharma Wins NMPA Nod for New Autoimmune Indication of Innovative Drug - TipRanks
Related explainers
Connected entities
Add Fifth Indication2 live mentionsNew Autoimmune Indication2 live mentionsHengrui Pharma Gets1 live mentionsNod1 live mentionsMoomoo Hengrui Pharma1 live mentionsGets Nod1 live mentionsMoomoo Moomoo1 live mentionsHengrui Pharma Wins1 live mentionsNMPA Nod1 live mentionsInnovative Drug1 live mentions
FAQ
What does this page track?
Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ivarmacitinib Sulfate Tablets.
Why might this page be noindex?
Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.
Where should readers verify facts?
Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.
Source diversity
2 distinct publisher/source names are currently connected to this entity page.